Abstract
Objectives
Clinical recognition of vascular acrosyndromes is often challenging. The term Raynaud’s phenomenon (RP) is commonly overused to describe any form of cold-related disorder. This study aims to formally evaluate peripheral vascular symptoms affecting the population, aged ≤ 40 years, and identify any correlations to joint hypermobility (JH).
Patients and methods
Fifty patients (31 males, 19 females) with vasomotor symptoms enrolled in this five-year prospective observational study. Clinical examination by a rheumatologist and a vascular surgeon was performed along with cardiology, echocardiographic and Doppler evaluation. Patients underwent blood cell count, biochemistry, thyroid and selectively immunologic testing. Twenty-four (48%) of them performed nailfold capillaroscopy. The SPSS for Windows, v.17.0, Chicago, USA, was used for the statistical analyses.
Results
Twenty-eight patients (56%) presented with erythromelalgia (EM), 6 (12%) with acrocyanosis (AC) and 9 (18%) as a combination of the above disorder. RP diagnosed in five (10%) while two patients (4%) presented as a mix of EM-RP. There was no correlation with abnormal laboratory tests. Increased incidence of JH was found in EM and AC patients. Among those who were tested with nailfold capillaroscopy, 75% had abnormalities ranged from mild to autoimmune-like diseases.
Conclusions
Erythromelalgia is the commonest functional vasculopathy in young population followed by acrocyanosis and a combination of these conditions. Joint hypermobility is markedly increased, indicating that dysautonomy may be considered the causative factor following a trigger event. Overall, RP was observed in 14% of patients. Clinical recognition of these disorders avoids unnecessary investigation.
Key Points • Vascular acrosyndromes in young adults are commonly functional disorders resembling vascular algodystrophy induced by thermic stress. • Dysautonomy of joint hypermobility is the co-factor influencing the appearance of the vascular disorders. • Raynaud’s phenomenon accounts to approximately 14% of vascular acrosyndromes presented in the young adult population. |
Similar content being viewed by others
References
Brand FN, Larson MG, Kannel WB, McGuirk JM (1997) The occurrence of Raynaud’s phenomenon in general population: the Framingham study. Vasc Med 2:296–301
Kumar P, Galarraga B, Belch JJF (2011) Raynaud’s phenomenon. In: Hochberg MC, Silman J, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology (5th Ed). Mosby Elsevier, Philadelphia, pp 1427–1432
Ventura I, Reid P, Jan R (2018) Approach to patients with suspected rheumatic disease. Prim Care Clin Office Pract 45:169–180
Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP et al (2016) Raynaud’s syndrome in children: systematic review and development of recommendations for assessment and monitoring. Clin Exp Rheumatol 34 (Suppl 100:200–206
Raynaud M. Local asphyxia and symmetrical gangrene of the extremities. Paris. L. Leclerc; 1862
Klippel JH (1991) Raynaud’s phenomenon. The French tricolor. Arch Intern Med 151:2389–2393
Valdovionos ST, Landry GJ (2014) Raynaud syndrome. Tech Vasc Interv Radiol 17:241–246
Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. Br J Rheumatol 32:357–361
Wigley FM (2002) Clinical practice. Raynaud’s phenomenon. N Engl J Med 347:1001–1008
LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–488
Maricq HR, Weinrich MC (1988) Diagnosis of Raynaud’s phenomenon assisted by color charts. J Rheumatol 15:454–459
Maverakis M, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y et al (2014) International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun 48–49::60–65. https://doi.org/10.1016/j.jaut.2014.01.020
Tang Z, Chen Z, Tang B, Jiang H (2015) Primary erythromelalgia: a review. Orphanet J Rare Dis 10:127. https://doi.org/10.1186/s13023-015-0347-1
Heidrich H (2010) Functional vascular diseases: Raynaud’s syndrome, acrocyanosis and erythromelalgia. Vasa 39:33–41. https://doi.org/10.1024/0301-1526/a000003
Kurklinsky AK, Miller VM, Rooke TW (2011) Acrocyanosis. The Flying Dutchman. Vasc Med 16:288–301
Mann N, King T, Murphy R (2019) Review of primary and secondary erythromelalgia. Clin Exp Dermatol. https://doi.org/10.1111/ced.13891
Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the hypermobility syndrome. Am J Med 115:33–40
Hakim AJ, Grahame R (2004) Non-musculoskeletal symptoms in joint hypermobility syndrome: indirect evidence for autonomic dysfunction. Rheumatology 43:1194–1195
Haberhauer G, Feytertag J, Hanusch-Enserer U, Dunky A (2000) Joint hypermobility syndrome and bilateral total occlusion of the ulnar arteries presenting as Raynaud’s phenomenon. Clin Exp Rheumatol 18:270–271
Beighton PH, Solomon L, Soskolne CL (1973) Articular mobility in an African population. Ann Rheum Dis 32:413–417
Hakim AJ, Grahame R (2003) A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract 57:163–166
Cutolo M, Smith V (2013) Nailfold capillaroscopy and other methods to assess the microvasculopathy in systemic sclerosis. In: Hachulla E, Czirjak L (eds) Eular, textbook on systemic sclerosis. BMJ Publising Group, London, pp 129–138
Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M (2006) Transition from primary Raynaud’s phenomenon to secondary Raynaud’s phenomenon identified by diagnosis of an associated disease. Arthritis Rheum 54:1974–1981
Leroux MB (2018) Erythromelalgia: a cutaneous manifestation of neuropathy? An Bras Dermatol 93:86–94
Pascarella A, Provitera V, Lullo F, Stancanelli A, Saltalamacchia AM, Caporaso G, Nolano M (2016) Evidence of small fiber neuropathy in a patient with Ehlers-Danlos syndrome, hypermobility-type. Clin Neurophysiol 127:1914–1916
Dean SM (2018) Cutaneous manifestations of chronic vascular disease. Prog Cardiovasc Dis 60:567–579
Fraenkel L, Zhang Y, Chaisson CE, Maricq HR, Evans SR, Brand F, Wilson PWF, Felson DT (1999) Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 42:306–310
Freedman RR, Mayes MD (1996) Familial aggregation of primary Raynaud’s disease. Arhtritis Rheum 39:1189–1191
Sivula A (1966) Vascular reactions in acrocyanosis. Angiology 17:269–274
Manios Y, Moschonis G, Lambrinou GP, Tsoutsoulopoulou K, Binou P, Karachaliou A et al (2018) A systematic review of vitamin D status in southern European countries. Eur J Nutr 57:2001–2036
Sideri V, Antonakos G, Fretzayas A, Attilakos A, Chrelias C, Papaevangelou V, Nicolaidou P, Papadopoulou A (2019) Hypovitaminosis D in healthy pregnant women and their newborns in Greece. Endocr Metab Immune Disord Drug Targets 19:159–165
Rajaei A, Dehghan P, Amiri A (2017) Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Caspian J Intern Med 8:269–274
Wigley F, Cutollo M (2013) Raynaud’s phenomenon. In Eular. Textbook on systemic sclerosis. Hachulla E, Czirjak L (Eds), BMJ Publishing Group Ltd, pp 115–128
Davis MD, O’Fallon WM, Rogers RS 3rd, Rooke TW (2000) Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol 136:330–336
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boirre G et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arhtritis Rheum 58:3902–3912
Pauling JD, Reilly E, Smith T, Frech TM (2018) Evolving symptoms of Raynaud’s phenomenon in systemic sclerosis are associated with physician and patient-reported assessments of disease severity. Arthritis Care Res. https://doi.org/10.1002/acr.23729
Funding
The study was supported by the Hellenic Rheumatology Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Patients were asked to participate in this prospective observational study and written informed consent was obtained, according to the Declaration of Helsinki. The study was approved by the Hospital’s Ethical Committee.
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vounotrypidis, P., Pyrpasopoulou, A., Sakellariou, G.T. et al. Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility. Clin Rheumatol 38, 2925–2932 (2019). https://doi.org/10.1007/s10067-019-04627-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04627-w